Question 1

What is Rapport Therapeutics, Inc.'s deferred tax assets and other non-current assets?

Accepted Answer

Rapport Therapeutics, Inc. (RAPP) reported deferred tax assets and other non-current assets of $1.06M in Q2 2026.

Question 2

How has Rapport Therapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?

Accepted Answer

Rapport Therapeutics, Inc.'s deferred tax assets and other non-current assets increased by 2.2% year-over-year, from $1.03M to $1.06M.

Question 3

What is the long-term trend for Rapport Therapeutics, Inc.'s deferred tax assets and other non-current assets?

Accepted Answer

Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s deferred tax assets and other non-current assets has grown at a 33.7% compound annual growth rate (CAGR), from $551K to $985K.

Question 4

What does deferred tax assets and other non-current assets mean?

Accepted Answer

Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Line item	June 30,2026	December 31,2025
Total current assets	446,856	498,561
Property and equipment, net	2,337	2,976
Operating lease right of use asset, net	8,732	9,909
Other assets	1,057	985
Total assets	$458,982	$512,431
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable	$2,796	$4,190

Deferred Tax Assets and Other Non-Current Assets at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Rapport Therapeutics, Inc.'s deferred tax assets and other non-current assets.

Rapport Therapeutics, Inc. RAPP Deferred Tax Assets and Other Non-Current Assets